Neonatal withdrawal symptoms associated with maternal use of pentazocine.
D001416:Back Pain / Q000188:drug therapy; D002164:Camphor / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003645:Death, Sudden; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D009892:Opium / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010423:Pentazocine / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced* / Q000188:drug therapy
D010276:Parasympatholytics; D002164:Camphor; D009892:Opium; D010423:Pentazocine; D002746:Chlorpromazine